1.
J Pediatric Infect Dis Soc
; 11(10): 471-473, 2022 Oct 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35904132
RESUMO
In this cohort of 42 adolescents with a previous multisystem inflammatory syndrome (MIS-C) diagnosis, 32 (76.2%) were vaccinated with COVID-19 vaccines, with a low incidence of relevant adverse events. More importantly, no new MIS-C or myocarditis occurred after a median of 10 weeks (range 5.3-19.7) post-vaccination.